Hefei-based Origin Quantum has demonstrated its computer’s ability to process medical imaging data ‘exponentially faster’ ...

Neglected tropical diseases (NTDs) consist of twenty conditions identified by the World Health Organization that ...

Chemists and chemical engineers have created a graphene-based supramolecular gel matrix that can control how pharmaceutical ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

In a study published in Angewandte Chemie International Edition, a research team integrated activity-based protein profiling ...

The AI-first drug design and development company plans to utilize the investment to advance its AI drug design engine, enhance software capabilities, finance drug development programs, and ...

a biotech company pioneering AI-driven drug design, told me. Yet Insilico has also used AI to help design multiple drugs that have successfully cleared early trials. The AI models that made ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...

Google DeepMind CEO Demis Hassabis envisions AI eradicating all diseases within a decade, potentially revolutionizing drug ...

By Michael J. de la Merced Reporting from London Over the last 12 months, Google’s efforts to use artificial intelligence to accelerate drug design have achieved breakthroughs in mimicking human ...